T1	p 44 75	children with acute diarrhoea .
T2	p 192 197	acute
T3	p 333 364	children with acute diarrhoea .
T4	p 373 398	Two hundred children were
T5	p 1182 1200	Four children from
T6	p 1452 1453	.
T7	p 1554 1562	children
T8	i 17 40	Saccharomyces boulardii
T9	i 113 131	Lactobacillus GG ,
T10	i 264 289	Saccharomyces boulardii .
T11	i 317 329	S. boulardii
T12	i 421 433	S. boulardii
T13	i 474 477	250
T14	i 481 530	( S. boulardii group ) or placebo ( placebo group
T15	i 757 769	S. boulardii
T16	i 788 795	placebo
T17	i 873 885	S. boulardii
T18	i 910 917	placebo
T19	i 968 980	S. boulardii
T20	i 1106 1118	S. boulardii
T21	i 1137 1144	placebo
T22	i 1205 1212	placebo
T23	i 1250 1262	S. boulardii
T24	i 1311 1329	placebo-controlled
T25	i 1351 1363	S. boulardii
T26	i 1454 1466	S. boulardii
T27	o 198 217	childhood diarrhoea
T28	o 648 655	medians
T29	o 663 686	average stool frequency
T30	o 822 843	duration of diarrhoea
T31	o 984 1000	watery diarrhoea
T32	o 1061 1086	duration of hospital stay
T33	o 1273 1295	persisting diarrhoea .
T34	o 1390 1417	duration of acute diarrhoea
T35	o 1426 1453	duration of hospital stay .
T36	o 1535 1550	acute diarrhoea